| Literature DB >> 35334894 |
José Ignacio Ramírez Manent1,2, Bárbara Altisench Jané1, Pilar Sanchís Cortés2,3, Carla Busquets-Cortés4,5, Sebastiana Arroyo Bote4,5, Luis Masmiquel Comas1,2, Ángel Arturo López González2,4,5.
Abstract
In December 2019, 27 cases of pneumonia were reported in Wuhan. In 2020, the causative agent was identified as a virus called SARS-CoV-2. The disease was called "coronavirus disease 2019" (COVID-19) and was determined as a Public Health Emergency. The main measures taken to cope with this included a state of lockdown. The aim of this study was to assess how the unhealthy lifestyles that ensued influenced different parameters. A prospective study was carried out on 6236 workers in a Spanish population between March 2019 and March 2021. Anthropometric, clinical, and analytical measurements were performed, revealing differences in the mean values of anthropometric and clinical parameters before and after lockdown due to the pandemic, namely increased body weight (41.1 ± 9.9-43.1 ± 9.9), BMI (25.1 ± 4.7-25.9 ± 4.7), and percentage of body fat (24.5 ± 9.1-26.9 ± 8.8); higher total cholesterol levels, with a statistically significant increase in LDL levels and a reduction in HDL; and worse glucose levels (90.5 ± 16.4-95.4 ± 15.8). Lockdown can be concluded to have had a negative effect on health parameters in both sexes in all age ranges, causing a worsening of cardiovascular risk factors.Entities:
Keywords: COVID-19; cardiovascular risk factors; disease; lockdown
Mesh:
Substances:
Year: 2022 PMID: 35334894 PMCID: PMC8953154 DOI: 10.3390/nu14061237
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1Flowchart of participants.
Characteristics of the population.
| Year 2018 | Year 2019 | Year 2020 | ||
|---|---|---|---|---|
| N = 6236 | Mean ± SD | Mean ± SD | Mean ± SD | |
| Age (years) | 41.1 ± 9.9 | 42.1 ± 9.9 | 43.1 ± 9.9 | <0.001 |
| Weight (kg) | 71.7 ± 16.3 | 72.2 ± 16.4 | 73.8 ± 16.5 | <0.001 |
| BMI (kg/m2) | 25.1 ± 4.7 | 25.3 ± 4,7 | 25.9 ± 4.7 | <0.001 |
| Waist circumference (cm) | 82.8 ± 14.0 | 84.6 ± 14.1 | 87.6 ± 14.1 | <0.001 |
| Hip circumference (cm) | 98.7 ± 9.4 | 99.8 ± 9.4 | 101.5 ± 9.5 | <0.001 |
| Waist to Height ratio | 0.49 ± 0.08 | 0.50 ± 0.08 | 0.52 ± 0.08 | <0.001 |
| Waist to hip ratio | 0.84 ± 0.10 | 0.85 ± 0.09 | 0.86 ± 0.09 | <0.001 |
| Body fat (%) | 24.5 ± 9.1 | 25.3 ± 8.7 | 26.9 ± 8.8 | <0.001 |
| SBP (mmHg) | 120.0 ± 16.8 | 121.3 ± 16.3 | 124.6 ± 16.3 | <0.001 |
| DBP (mmHg) | 76.9 ± 10.7 | 78.2 ± 10.5 | 82.8 ± 10.6 | <0.001 |
| Glycaemia (mg/dL) | 90.5 ± 16.4 | 91.9 ± 15.7 | 95.4 ± 15.8 | <0.001 |
| Total cholesterol (mg/dL) | 190.7 ± 37.3 | 194.3 ± 35.3 | 202.8 ± 35.7 | <0.001 |
| HDL-c (mg/dL) | 53.9 ± 13.7 | 53.1 ± 13.4 | 50.7 ± 13.7 | <0.001 |
| LDL-c (mg/dL) | 117.4 ± 40.3 | 121.4 ± 38.5 | 131.0 ± 39.0 | <0.001 |
| Triglycerides (mg/dL) | 96.8 ± 79.2 | 98.7 ± 78.5 | 105.8 ± 78.9 | <0.001 |
| N (%) | N (%) | N (%) | ||
| Smokers | 1176 (18.9) | 1202 (19.3) | 1302 (20.9) | <0.001 |
| Physical exercise | 2732 (43.8) | 2600 (41.7) | 2044 (32.8) | <0.001 |
| Normal weight | 3500 (56.1) | 3398 (54.5) | 3085 (49.5) | <0.001 |
| Overweight | 1890 (30.3) | 1978 (31.7) | 2144 (34.4) | |
| Obesity | 846 (13.6) | 860 (13.8) | 1007 (16.1) | |
| Waist to height ratio high | 2526 (40.5) | 2826 (45.3) | 3368 (54.0) | <0.001 |
| Waist to hip ratio high | 1460 (23.4) | 1612 (25.8) | 1944 (31.2) | <0.001 |
| Body fat normal | 4115 (66.0) | 3996 (64.1) | 3722 (59.7) | <0.001 |
| Body fat high | 1394 (22.4) | 1428 (22.9) | 1466 (23.5) |
SBP: systolic blood pressure; DBP: diastolic blood pressure; HDL: high density lipoproteins; LDL: low density lipoproteins.
Changes in anthropometric, clinical, laboratory, and healthy habit variables in different pre-COVID and COVID years.
| 2018–2019 Change | 2019–2020 Change | |
|---|---|---|
| Weight (kg) | 0.47 ± 1.04 | 1.61 ± 1.28 |
| BMI (kg/m2) | 0.16 ± 0.37 | 0.57 ± 0.46 |
| Waist circumference (cm) | 1.82 ± 4.87 | 2.92 ± 1.17 |
| Hip circumference (cm) | 1.14 ± 0.85 | 1.69 ± 1.15 |
| Waist to Height ratio | 0.01 ± 0.03 | 0.02 ± 0.01 |
| Waist to hip ratio | 0.01 ± 0.05 | 0.01 ± 0.02 |
| Body fat (%) | 0.88 ± 2.14 | 1.58 ± 1.68 |
| SBP (mmHg) | 1.28 ± 4.08 | 3.26 ± 3.68 |
| DBP (mmHg) | 1.35 ± 1.48 | 4.62 ± 1.82 |
| Glycaemia (mg/dL) | 1.47 ± 5.16 | 3.49 ± 2.30 |
| Total cholesterol (mg/dL) | 3.59 ± 17.30 | 8.52 ± 13.40 |
| HDL-c (mg/dL) | −0.82 ± 3.97 | −2.44 ± 1.78 |
| LDL-c (mg/dL) | 4.04 ± 17.64 | 9.54 ± 13.41 |
| Triglycerides (mg/dL) | 1.83 ± 8.74 | 7.09 ± 4.63 |
Figure 2Changes in cardiovascular risk factors in 2018, 2019, and 2020: BMI, waist, lean mass, glucose, blood pressure, and total cholesterol.
Figure 3Relative Risk (RR) of patients who had worsened cardiovascular risk factors in the 2019–2020 season when compared with the 2018–2019 season. Patients were considered to have worsened when they changed to a worse category in the corresponding risk factor: BMI (normal, overweight, obesity); glycemic status (normal, prediabetes, diabetes); blood pressure status (normal, pre-AHT, AHT1, AHT2); waist (normal, high); fat mass (normal, high); total cholesterol (normal, high); LDL (normal, high, very high); HDL (normal, low); and TG (normal, high).
Relative risk of patients with increased BMI, waist, fat mass, glycemic status, and hypertension status divided into categories of age, sex, BMI, glycemic status, and hypertension status. Patients were considered to have worsened when they changed to an upper category in the corresponding risk factor: BMI (normal, overweight, obesity); glycemic status (normal, prediabetes, diabetes); blood pressure status (normal, pre-AHT, AHT1, AHT2); waist (normal, high); fat mass (normal, high, very high); total cholesterol (normal, high); LDL (normal, high); HDL (normal, low); TG (normal, high).
| BMI | Glucemic Status | Blood Pressure | Waist | Fat Mass | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RR | (95% CI) | RR | (95% CI) | RR | (95% CI) | RR | (95% CI) | RR | (95% CI) | |||||||
| Age | <0.001 | <0.001 | <0.001 | <0.001 | 0.907 | |||||||||||
| <35 | 1.008 | (1.001–1.014) | 1.010 | (1.001–1.019) | 1.223 | (1.186–1.261) | 1.009 | (0.997–1.020) | 1.084 | (1.062–1.106) | ||||||
| 35–40 | 1.021 | (1.012 1.030) | 1.021 | (1.008–1.035) | 1.287 | (1.234–1.343) | 1.013 | (1.000–1.027) | 1.037 | (1.015–1.060) | ||||||
| 40–50 | 1.020 | (1.013–1.028) | 1.022 | (1.011–1.034) | 1.323 | (1.283–1.365) | 1.017 | (1.004–1.029) | 1.022 | (1.007–1.037) | ||||||
| >50 | 1.029 | (1.018–1.041) | 1.021 | (1.004–1.038) | 1.284 | (1.235–1.336) | 0.999 | (0.975–1.023) | 1.064 | (1.042–1.087) | ||||||
| Gender | 0.453 | <0.001 | <0.001 | <0.001 | <0.001 | |||||||||||
| man | 1.024 | (1.017–1.031) | 1.022 | (1.011–1.033) | 1.372 | (1.335–1.411) | 1.002 | (0.991–1.013) | 0.971 | (0.957–0.985) | ||||||
| women | 1.015 | (1.010–1.021) | 1.014 | (1.007–1.021) | 1.212 | (1.186–1.238) | 1.022 | (1.011–1.032) | 1.125 | (1.112–1.139) | ||||||
| BMI | 0.241 | <0.001 | <0.001 | 0.704 | ||||||||||||
| Normal | - | 0.986 | (1.007–1.021 | 1.230 | (1.204–1.257) | 1.008 | (1.004–1.011) | 1.075 | (1.061–1.089) | |||||||
| Overweight | - | 0.998 | (0.980–1.024) | 1.293 | (1.252–1.335) | 1.044 | (1.022–1.066) | 1.009 | (0.993–1.025) | |||||||
| Obesity | - | 0.968 | (1.019–1.045) | 1.516 | (1.431–1.606) | 0.954 | (0.927–0.982) | 1.038 | (1.014–1.063) | |||||||
| Glucemic status | 0.065 | 0.004 | 0.001 | 0.235 | 0.013 | |||||||||||
| NORMAL | 1.015 | (1.011–1.020) | (-) | 1.061 | (1.050–1.073) | 1.017 | (1.009–1.025) | 1.029 | (1.016–1.043) | |||||||
| prediabetes | 1.041 | (1.027–1.055) | (-) | 0.989 | (0.967–1.011) | 0.977 | (0.954–1.002) | 1.028 | (1.001–1.056) | |||||||
| diabetes | 1.031 | (0.996–1.067) | (-) | 0.993 | (0.934–1.056) | 1.050 | (0.978–1.129) | 1.070 | (0.979–1.170) | |||||||
| Blood Pressure | <0.001 | 0.280 | <0.001 | <0.001 | ||||||||||||
| normal | 1.011 | (1.006 1.017) | 1.015 | (1.004 1.025 | (-) | 1.018 | (1.005 1.031) | 1.102 | 1.085 1.119 | |||||||
| preHTA | 1.023 | (1.016–1.030) | 1.016 | (1.007–1.025) | (-) | 1.016 | (1.005–1.028) | 1.033 | (1.019–1.048) | |||||||
| HTA 1 | 1.019 | (1.007–1.030) | 1.021 | (1.004–1.038) | (-) | 0.990 | (0.972–1.009) | 0.994 | (0.970–1.019) | |||||||
| HTA 2 | 1.033 | (1.008–1.059) | 1.042 | (1.010–1.073) | (-) | 1.002 | (0.964–1.042) | 1.026 | (0.983–1.072) | |||||||
Relative Risk of patients with increased total cholesterol, LDL, TG and a decrease in HDL levels, divided by categories of age, sex, BMI, glycemic status and hypertension status. Patients were deemed to have worsened when they changed to an upper category in the corresponding risk factor: BMI (normal, overweight, obesity); glycemic status (normal, prediabetes, diabetes); blood pressure status (normal, pre-AHT, AHT1, AHT2); waist (normal, high); fat mass (normal, high, very high); total cholesterol (normal, high); LDL (normal, high); HDL (normal, low); and TG (normal, high).
| Total Cholesterol | HDL | LDL | TG | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RR | (95% CI) | RR | (95% CI) | RR | (95% CI) | RR | (95% CI) | ||||||
| Age | 0.001 | 0.958 | <0.001 | 0.902 | |||||||||
| <35 | 1.049 | (1.020–1.139) | 1.047 | (1.027–1.068) | 1.047 | (1.025–1.069) | 1.012 | (1.004–1.021) | |||||
| 35–40 | 1.049 | (1.021–1.078) | 1.028 | (0.998–1.059) | 1.017 | (0.991–1.044) | 1.004 | (0.994–1.015) | |||||
| 40–50 | 1.089 | (1.066–1.113) | 1.028 | (1.011–1.046) | 1.048 | (1.026–1.069) | 0.999 | (0.994–1.004) | |||||
| >50 | 1.008 | (0.982–1.035) | 1.044 | (1.022–1.068) | 0.982 | (0.955–1.011) | 1.000 | (0.990–1.010) | |||||
| Gender | <0.001 | 0.000 | 0.040 | 0.643 | |||||||||
| Men | 1.061 | (1.044–1.080) | 1.078 | (1.059–1.097) | 1.018 | (1.001–1.035) | 0.999 | (0.993–1.006) | |||||
| Women | 1.081 | (1.062–1.099) | 1.002 | (0.990–1.014) | 1.041 | (1.024–1.058) | 1.008 | (1.003–1.012) | |||||
| BMI category | 0.027 | 0.000 | 0.327 | 0.220 | |||||||||
| Normal | 1.092 | (1.074–1.110) | 1.046 | (1.033–1.060) | 1.040 | (1.024–1.057) | 1.004 | (0.999–1.010) | |||||
| Overweight | 1.049 | (1.027–1.071) | 0.989 | (0.958–1.021) | 1.011 | (0.979–1.045) | 1.006 | (0.999–1.013) | |||||
| Obesity | 1.041 | (1.007–1.075) | 1.038 | (1.017–1.060) | 1.011 | (0.979–1.045) | 0.995 | (0.984–1.006) | |||||
| Glucemic status | 0.113 | 0.015 | 0.003 | 0.596 | |||||||||
| Normal | 1.066 | (1.052–1.080) | 1.004 | (1.000–1.009) | 1.277 | (1.253–1.301) | 1.034 | (1.023–1.046) | |||||
| prediabetes | 1.111 | (1.079–1.143) | 0.996 | (0.987–1.006) | 1.299 | (1.237–1.365) | 1.066 | (1.033–1.099) | |||||
| diabetes | 1.002 | (0.932–1.077) | 1.042 | (1.001–1.084) | 1.506 | (1.272–1.783) | 0.866 | (0.774–0.969) | |||||
| Blood Pressure | <0.001 | 0.006 | 0.072 | 0.036 | |||||||||
| normal | 1.106 | (1.081–1.132) | 1.005 | 0.987 1.024 | 1.040 | (1.018 1.062) | 1.004 | 0.996 1.013 | |||||
| preHTA | 0.545 | (0.464–0.641) | 1.055 | (1.039–1.071) | 1.026 | (1.009–1.044) | 1.007 | (1.001–1.012) | |||||
| HTA 1 | 0.639 | (0.478–0.853) | 1.059 | (1.030–1.089) | 1.022 | (0.992–1.053) | 0.997 | (0.990–1.004) | |||||
| HTA 2 | 1.053 | (0.620–1.787) | 1.003 | (0.955–1.053) | 1.023 | (0.979–1.069) | 0.999 | (0.981–1.017) | |||||
Percentage of physical activity, before and during lockdown in men and women separated into groups according to whether or not they previously performed physical activity.
| Year 2018 | Year 2019 | Year 2020 | ||
|---|---|---|---|---|
| Women non physical exercise | 57.0 | 57.4 | 69.2 | <0.0001 |
| Women yes physical exercise | 43.0 | 42.6 | 30.8 | |
| Men non physical exercise | 55.3 | 59.3 | 65.1 | <0.0001 |
| Men yes physical exercise | 44.7 | 40.7 | 34.9 |